Search results for: 'disease of inspect'

Since the onset of the COVID-19 pandemic, molecular diagnostics mergers/acquisition transactions and product launches for infectious disease testing are indicating a pivot toward a new direction or an enhancement of portfolios. The emergence of saliva sample testing and the transition to PCR-based syndromic and direct-to-consumer testing for respir...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

This study provides insights across recent advances across the use of animal disease models in preclinical research.It encompasses the following aspects: Technology roadmap, market trends, capabilities, and targeted application Stakeholder activities, influence, industry initiatives Investment environment and funding support Industry evolution and ...

Before the introduction of Internet of Things (IoT) technologies in healthcare, patients’ interactions with doctors were often limited to clinic visits, text or tele communications. Due to this doctors were not able to monitor patients’ health continuously and this was affecting the overall treatment outcome. To address this clinical concern, resea...

The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...

At present, only a few therapies are available with relatively low success. Both, the clinical and the scientific communities are critically devoted to develop new therapeutic approaches to treat and diagnose neurodegenerative diseases. At present days, neurodegenerative diseases represent one of the main causes of death in the industrialized econ...

Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and genetic diseases. More than 80% of rare diseases are genetic in origin, so that gene and cell therapies are being...

The non-destructive testing (NDT) inspection services market rebounded in 2017 after two years of negative growth. It is expected to transform over the next five years with the advent of new technologies, changing customer requirements regarding connectivity and analytics features, and novel business models. The market was worth $8.79 billion in 20...